To confirm that surface enhanced PD‐L1 in chi‐G4S‐DR5 stable 4T1 tumor works by inhibiting effector CD8+ T‐cell function via PD‐1 engagement, next we depleted CD8+ T cells in tumor‐bearing animals (Fig 5J and K). This evidence concerns the gene CD8A and neoplasm.